• No results found

University of Groningen Breaking walls: combined peptidic activities against Gram-negative human pathogens Li, Qian

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Breaking walls: combined peptidic activities against Gram-negative human pathogens Li, Qian"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Breaking walls: combined peptidic activities against Gram-negative human pathogens

Li, Qian

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date:

2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Li, Q. (2019). Breaking walls: combined peptidic activities against Gram-negative human pathogens.

University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

PROPOSITIONS

Associated with the PhD thesis

Breaking walls: combined peptidic activities against

Gram-negative human pathogens

Qian Li

1. The development of antibiotic resistance is a natural ecological phenomenon, but the abuse and misuse of antibiotics is accel-erating the process. 2. Lantibiotic structures can be used as guidance for designing novel non-lantibiotic and lantibiotic peptides (Rink et al., 2005; Schmitt et al., 2019). 3. The protective outer-membrane of Gram-negative bacteria acts as an efficient barrier to prevent the action of several antibiotics (Jessica M. A. Blair, 2015). 4. Existing antibiotics against Gram-positive bacteria to which resistance is abundant could have a second life against Gram- negative pathogens when used in synergy with outer membrane perturbing agents (this thesis) 5. Production of modified peptides in good quantity and high ho-mogeneity remains challenging. 6. It is possible to develop highly potent lantibiotic derivatives spe-cifically targeting Gram-negative bacteria, by rational design of nisin (Chapter 3). 7. Vancomycin/nisin and outer membrane disrupting peptides dis-play strong synergistic activity against selected Gram- negative pathogens (Chapter 4 and Chapter 5). 8. GNP-D8 is very promising to be registered as an adjuvant in clin-ical use against Gram-negative human pathogens (Chapter 5). 9. Three cobblers combined make a genius mind (三个臭皮匠, 顶个诸葛亮)(Chinese proverb). 10. When the going gets tough, the tough gets going.

Referenties

GERELATEERDE DOCUMENTEN

Indien die “bloedige hand” beginsel van toepassing is, sal dit nie saak maak of die bate verkoop word of aan een van die ander begunstigdes toegewys word nie, omrede

Van die positiewe gevolge wat die vernuwing van denke ten doel het, is onder andere meer beheer oor die denke, die vermoë om bewustelik innerlike oortuigings te hersien en

The work described in this thesis was carried out in Molecular Genetics Group of the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) of the University of

1 bacteria but not against Gram-negative bacteria because of the low penetrating capacity of the outer-membrane. If nisin/vancomycin can reach the inner-membrane of

For all the type B peptides, the fully dehydrated hybrid peptides were obtained in addition to partly dehydrated peptides, and we observed that the different cleavage sites

In those mutants, full nisin or parts of nisin were fused to different tails with reported activity against Gram negative bacteria to create antimicrobial peptides target- ed

Here, designed peptides (further termed GNPs), either alone or combined with vancomycin or nisin, were tested against selected Gram- negative pathogens demonstrating

The in vitro antimicrobial activity tests of vancomycin and GNP-D8, in the presence of human plasma, either alone or in combination, were performed against three selected